A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
A junior doctor launches a scathing attack on Health Secretary saying: "Sc*** you Jeremy Hunt, you've picked a fight with the wrong crowd".
A British citizen was likely taken to China against his will in a 'serious breach' of a bilateral agreement with the UK, a report says.
Atheist Richard Dawkins has cancelled his Australia and New Zealand tour after suffering from a 'minor stroke', his management said.